
Options Corner: Bullish Traders Eye Eli Lilly As Market Signals Hint At A Turnaround
While multinational pharmaceutical firm Eli Lilly and Company LLY represents one of the top drugmakers in the world, that status alone hasn't exempted its equity from underperformance. In the past 52 weeks, LLY stock finds itself down almost 16%. Since …